Drug recall · September 8, 2021
Donepezil HCL Tablets recall
Why: Subpotent
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Donepezil HCL Tablets, USP, 5 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801 NDC 59746-329-90
- Lots / codes
Lot # DN120006A, exp. date 12/2021
- Quantity
- 14,544 bottles
- Company
- Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD
- Distribution
- Product was distributed nationwide.
- Initiated
- August 20, 2021 · Voluntary: Firm initiated
- Classified
- August 31, 2021
- Reported
- September 8, 2021
- Ended
- April 5, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Donepezil
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.